Conjunctivitis Treatment Market Share

North American Market Forecast   

North America industry is poised to hold largest revenue share of 36% by 2037. The growth of the market can be attributed majorly to the increasing occurrence of conjunctivitis, coupled with the growing use of corrective lenses by individuals in the region. For instance, as per the estimations, in the United States, nearly 60% of people aged 26-40 and 90% of people aged 70 wear corrective lenses. Hyperopia, astigmatism, myopia, and presbyopia treatment are typically done with the corrective lenses. In addition, corrective lenses are designed to assist the eyes in properly focusing light onto the retinas so that an individual can see properly. Further, the presence of a strong healthcare infrastructure in the region, along with the presence of major key players, is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare expenditure and rising advancements in conjunctivitis treatment are also anticipated to boost market growth during the forecast period.

APAC Market Statistics

Furthermore, the Asia Pacific conjunctivitis treatment market is projected to display faster growth over the forecast period on the back of the escalating count of research and development activities, coupled with the increasing healthcare expenditure in the region. Based on the World Bank statistics, health expenditure in East Asia and the Pacific increased from 6.51% of total GDP in 2018 to 6.67% of GDP in 2019. Besides this, the surging ratio of aged patients, along with the development of healthcare facilities in the region are also projected to accelerate the market growth further throughout the forecast period in the APAC region.